CGVHD
Clinical trials for CGVHD explained in plain language.
Never miss a new study
Get alerted when new CGVHD trials appear
Sign up with your email to follow new studies for CGVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for transplant patients when standard treatment fails
Disease control Not yet recruitingThis early-stage study is testing whether adding the drug sarilumab helps adults with chronic graft-versus-host disease (cGVHD) when their current treatment (belumosudil) isn't working well. Researchers will check if the combination is safe and shows any signs of helping control …
Matched conditions: CGVHD
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New hope for transplant patients battling debilitating rejection disease
Disease control Not yet recruitingThis early-stage study is testing an experimental drug called Gecacitinib for people with chronic graft-versus-host disease (cGVHD) that doesn't improve with standard steroid treatment. The trial will first find a safe dose and then see if the drug helps control the disease and i…
Matched conditions: CGVHD
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC